Diabetic Kidney Disease - Semaglutide Flows into the Mainstream.

Herrington WG., Haynes R.

DOI

10.1056/NEJMe2406408

Type

Journal article

Journal

N Engl J Med

Publication Date

11/07/2024

Volume

391

Pages

178 - 179

Keywords

Humans, Glucagon-Like Peptides, Diabetic Nephropathies, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Glucagon-Like Peptide-1 Receptor, Drug Approval

Permalink Original publication